Wells Fargo analyst Mike Mayo maintained a Buy rating on Citigroup (C – Research Report) today and set a price target of $95.00. The ...

Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.

Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen (NASDAQ:AMGN), ...

Producers of dynamic random access memory, or DRAM, which includes Micron Technology, Samsung and SK Hynix, should see ...

Many or all of the products on this page are from partners who compensate us when you click to or take an action on their website, but this does not influence our evaluations or ratings.

Large Cap financials underperformed for much of the last two years The biggest banks also have strong brokerage units ...

After dropping over 20% in two days last month following a downbeat forecast for the next fiscal year, ASML ( ASML 0.63%) ...